Study Evaluating Single Doses of PPM-204 on the Electrical Pathways of the Heart

Completed · Phase 1

Conditions studied: Diabetes Mellitus

In brief

A study evaluating the safety of a high and low dose of PPM-204 on the electrical pathways of the heart.

Key facts

Study ID

NCT00447629

Run by

Wyeth is now a wholly owned subsidiary of Pfizer

Starts

2007-01-01

Expected to finish

2007-03-01

Last updated by the study team

2007-12-05

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Men or women, aged 18 to 55 years
• Body mass index in the range of 18 to 30 kg/m2
• Healthy as determined by the investigator on the basis of medical history, physical examination, clinical laboratory test results, vital signs, and 12-lead ECG

You may not qualify if…

• History of cardiac, thyroid, muscle, or kidney abnormalities
• A family history of long QT syndrome and/or sudden cardiac death
• History of any clinically significant drug allergy, hypersensitivity to sulfonomides or the quinolone class of antibiotics

Where it is running

• Study site — Phoenix, Arizona, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.